These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26871198)

  • 1. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
    Pérez CA; Garcia SS; Yu RD
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced extrapyramidal reactions.
    Teoh L; Allen H; Kowalenko N
    J Paediatr Child Health; 2002 Feb; 38(1):95-7. PubMed ID: 11869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 4. Tardive Oculogyric Crisis With Low-Dose Antipsychotic in an Adolescent: A Case Report.
    Gnanavel S
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30476369
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Extrapyramidal side effects with low-dose risperidone.
    Pies R
    Can J Psychiatry; 1997 Oct; 42(8):881. PubMed ID: 9356779
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder.
    Karpuz D; Hallioglu O; Toros F; Tasdelen B
    J Electrocardiol; 2017; 50(4):410-415. PubMed ID: 28274540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit syndrome induced by combined lithium and risperidone.
    Mendhekar DN
    Can J Psychiatry; 2005 May; 50(6):369. PubMed ID: 15999955
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal side effects in a patient treated with risperidone plus donepezil.
    Magnuson TM; Keller BK; Burke WJ
    Am J Psychiatry; 1998 Oct; 155(10):1458-9. PubMed ID: 9766783
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not just another antipsychotic-for-conduct-problems trial.
    Blader JC
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
    [No Abstract]   [Full Text] [Related]  

  • 12. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulants and neuroleptic withdrawal dyskinesia.
    Connor DF
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):247-8. PubMed ID: 9519625
    [No Abstract]   [Full Text] [Related]  

  • 15. Extrapyramidal symptoms resulting from risperidone use in a four year old child: A case report.
    Elahi E; Zia U; Bhutta OA; Andleeb S
    J Pak Med Assoc; 2018 Nov; 68(11):1719-1720. PubMed ID: 30410159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant-atypical antipsychotic interaction and acute dystonia.
    Benjamin E; Salek S
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary retention caused after fluoxetine-risperidone combination.
    Bozikas V; Petrikis P; Karavatos A
    J Psychopharmacol; 2001 Jun; 15(2):142-3. PubMed ID: 11448089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Windhaber J; Urbanits S; Grisold W
    Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
    Carnahan RM; Lund BC; Perry PJ; Chrischilles EA
    Acta Psychiatr Scand; 2006 Feb; 113(2):135-41. PubMed ID: 16423165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.